Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Payables (2016 - 2025)

Historic Payables for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $174.6 million.

  • Surgery Partners' Payables rose 222.48% to $174.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $174.6 million, marking a year-over-year increase of 222.48%. This contributed to the annual value of $208.7 million for FY2024, which is 2147.85% up from last year.
  • Latest data reveals that Surgery Partners reported Payables of $174.6 million as of Q3 2025, which was up 222.48% from $174.9 million recorded in Q2 2025.
  • In the past 5 years, Surgery Partners' Payables ranged from a high of $208.7 million in Q4 2024 and a low of $96.0 million during Q1 2021
  • Its 5-year average for Payables is $148.7 million, with a median of $148.8 million in 2023.
  • Per our database at Business Quant, Surgery Partners' Payables crashed by 1011.24% in 2021 and then surged by 3231.94% in 2024.
  • Surgery Partners' Payables (Quarter) stood at $124.9 million in 2021, then increased by 21.38% to $151.6 million in 2022, then increased by 13.32% to $171.8 million in 2023, then increased by 21.48% to $208.7 million in 2024, then fell by 16.34% to $174.6 million in 2025.
  • Its Payables stands at $174.6 million for Q3 2025, versus $174.9 million for Q2 2025 and $165.0 million for Q1 2025.